Arie Belldegrun

Insider Reports History

Location
Los Angeles, CA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Arie Belldegrun:

Company Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. Director Common Stock 2,236,816 $3,981,532 $1.78 24 Jan 2025 Direct
Allogene Therapeutics, Inc. Director Common Stock 539,867 $960,963 $1.78 24 Jan 2025 Indirect
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 500,000 $274,500 $0.5490 12 Jun 2024 By Bellco Legacy LLC
Ginkgo Bioworks Holdings, Inc. Director Restricted Stock Units 432,900 $237,662 $0.5490 13 Jun 2024 Direct
Ginkgo Bioworks Holdings, Inc. Director Class A Common Stock 194,925 $107,014 $0.5490 12 Jun 2024 Direct
Kronos Bio, Inc. Director Common Stock 0 $0 $0.5700 20 Jun 2025 By Bellco Legacy II Trust
Kronos Bio, Inc. Director Common Stock 0 $0 $0.5700 20 Jun 2025 By Vida Ventures, LLC
Allogene Therapeutics, Inc. Director Stock Option (Right to buy) 1,307,927 24 Jan 2025 Direct
Ginkgo Bioworks Holdings, Inc. Director Stock Option 571,428 13 Jun 2024 Direct
UroGen Pharma Ltd. Director Stock Option (right ot buy) 20,000 26 Aug 2025 Direct
Kronos Bio, Inc. Director Stock Option (Right to Buy) 0 20 Jun 2025 Direct

Insider Reports Filed by Arie Belldegrun

Symbol Company Period Transactions Value $ Form Type Role Filing Time
URGN UroGen Pharma Ltd. 26 Aug 2025 1 $0 4 Director 27 Aug 2025, 16:36
KRON Kronos Bio, Inc. 20 Jun 2025 6 -$1,963,587 4 Director 20 Jun 2025, 16:15
ALLO Allogene Therapeutics, Inc. 24 Jan 2025 2 $0 4 Director 28 Jan 2025, 20:11
URGN UroGen Pharma Ltd. 06 Aug 2024 1 $0 4 Director 08 Aug 2024, 09:11
KRON Kronos Bio, Inc. 25 Jun 2024 1 $0 4 Director 26 Jun 2024, 16:31
DNA Ginkgo Bioworks Holdings, Inc. 12 Jun 2024 4 $0 4 Director 14 Jun 2024, 16:26
ALLO Allogene Therapeutics, Inc. 16 May 2024 2 +$5,999,998 4 Director 20 May 2024, 21:33
ALLO Allogene Therapeutics, Inc. 25 Jan 2024 2 $0 4 Director 31 Jan 2024, 17:46
URGN UroGen Pharma Ltd. 07 Sep 2023 1 $0 4 Director 08 Sep 2023, 15:43
KRON Kronos Bio, Inc. 22 Jun 2023 1 $0 4 Director 26 Jun 2023, 16:08
DNA Ginkgo Bioworks Holdings, Inc. 16 Jun 2023 2 $0 4 Director 21 Jun 2023, 17:03
ALLO Allogene Therapeutics, Inc. 22 Mar 2023 2 $0 4 Director 24 Mar 2023, 20:14
URGN UroGen Pharma Ltd. 14 Sep 2022 2 +$800,000 4 Director 16 Sep 2022, 15:13
URGN UroGen Pharma Ltd. 31 Aug 2022 2 +$16,205 4 Director 02 Sep 2022, 11:40
KRON Kronos Bio, Inc. 22 Jun 2022 1 $0 4 Director 29 Jun 2022, 16:06
DNA Ginkgo Bioworks Holdings, Inc. 10 Jun 2022 2 $0 4 Director 13 Jun 2022, 21:13
URGN UroGen Pharma Ltd. 08 Jun 2022 1 $0 4 Director 10 Jun 2022, 15:37
ALLO Allogene Therapeutics, Inc. 23 Mar 2022 1 $0 4 Director 25 Mar 2022, 17:50
ALLO Allogene Therapeutics, Inc. 14 Mar 2022 2 $0 4/A Director 01 Apr 2022, 17:40
ALLO Allogene Therapeutics, Inc. 12 Jan 2022 1 +$1,953,491 4 Director 14 Jan 2022, 11:02
DNA Ginkgo Bioworks Holdings, Inc. 16 Sep 2021 0 $0 3/A Director 28 Mar 2022, 17:30
KRON Kronos Bio, Inc. 22 Jun 2021 1 $0 4 Director 23 Jun 2021, 21:14
URGN UroGen Pharma Ltd. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 13:41
ALLO Allogene Therapeutics, Inc. 24 May 2021 2 +$6,906,583 4 Director 25 May 2021, 08:00
URGN UroGen Pharma Ltd. 26 Mar 2021 2 +$16,205 4/A Director 09 Jun 2021, 13:47